Thank you, Justin. Good morning, everybody, and thank you for joining us to discuss what has been a pivotal quarter for ARS ...
ARS Pharmaceuticals, Inc. ( SPRY) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Good morning and welcome to ARS Pharmaceuticals Conference Call. [Operator Instructions] Please be advised that ...
Medicus Pharma is advancing Teverelix, a recently acquired, clinical stage asset, designed to address limitations of current ...
UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM ESTCompany ParticipantsAndrew Dickinson - Chief ...
Today, Neros has closed its $75M Series B fundraising led by Sequoia Capital with participation from Vy Capital US and ...
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
One of the terms you are likely to hear during your fertility treatment is Lupride injections. Starting fertility treatments ...
A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback